Skip to main content
Normal View

Dáil Éireann debate -
Tuesday, 26 Mar 1996

Vol. 463 No. 3

Written Answers. - Indicative Drug Target Scheme.

Mary Wallace

Question:

118 Miss M. Wallace asked the Minister for Health the concerns, if any, he has regarding the approach of the Irish Medical Organisation to promoting the indicative drug budgeting scheme; the targeting of certain GMS general practitioners; and if he will make a statement on the matter. [6262/96]

Limerick East): The Indicative Drug Target — IDT — scheme was introduced in January 1993 following agreement between the Department, the health boards and the Irish Medical Organisation arising out of the review of the general medical services scheme the previous year. All parties to the agreement recognised that there was scope for an improvement in prescribing practices leading to better patient care and better use of finite resources.

The IDT scheme forms part of an integrated strategy to rationalise the cost and make more effective use of prescribed drugs and medicines within the State. The scheme encourages doctors to examine their prescribing practices with a view to availing of opportunities to achieve more effective prescribing. To assist in this process, from 1993 onwards, doctors were provided with indicative drug targets each year constructed on the basis of average prescribing costs weighted by age and sex factors. General practioners who make savings against their targets are allowed to use a portion of the amount saved for investment in their own practices while the remaining portion is used by the health boards for investment in general practices in their respective areas.

All parties to the agreement recognise that the IDT scheme provides a realistic mechanism for securing investment funding for general practice. Consequently, there is a co-operative approach taken to the implementation of the scheme between the Department, the health boards and the IMO. It is evident that the greater the number of doctors involved in the scheme, the greater is the benefit to general practice nationally. To this end the IMO plays its part, at local meetings, in encouraging GPs to become more involved in the scheme. However, the IDT scheme is purely voluntary and the individual general practitioner retains the right to prescribe as he-she considers necessary.
Top
Share